- Published at
- by gurufocus.com
neutral
neutral
SkinBioTherapeutics PLC (LSE:SBTX) Full Year 2024 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions
Revenue: £1.2 million for the fiscal year, up from £100,000 the prior year.Projected Revenue: Analyst guidance projects £5.3 million, with a full-year pro f